CSBR icon

Champions Oncology
CSBR

Overview Fund Activity

29 hedge funds and large institutions have $35.6M invested in Champions Oncology in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 10 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
29
Holders Change
+1
Holders Change %
+3.57%
% of All Funds
0.46%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
4
Reduced
10
Closed
2
Calls
$91K
Puts
$29K
Net Calls
+$62K
Net Calls Change
+$1.94M

Top Buyers

1
UBS Group
1
UBS Group
Switzerland
$19.4K
2
Geode Capital Management
2
Geode Capital Management
Massachusetts
$382K
3
Simplex Trading
3
Simplex Trading
Illinois
$6K
4
Renaissance Technologies
4
Renaissance Technologies
New York
$781K
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$427K

Top Sellers

1
Dimensional Fund Advisors
1
Dimensional Fund Advisors
Texas
$367K
2
SFI
2
Susquehanna Fundamental Investments
Pennsylvania
$0
3
Millennium Management
3
Millennium Management
New York
$208K
4
Stifel Financial
4
Stifel Financial
Missouri
$64.8K
5
EIM
5
Essex Investment Management
Massachusetts
$654K
Name Holding Trade Value Shares
Change 		Shares
Change %
Wells Fargo
26
Wells Fargo
California
$267 -$12 -2 -4%
TRCT
27
Tower Research Capital (TRC)
New York
$130 +$93 +15 +250%
JPMorgan Chase & Co
28
JPMorgan Chase & Co
New York
$68 – – –
SFI
29
Susquehanna Fundamental Investments
Pennsylvania
– -$97.2K -15,449 Closed
GC
30
Globeflex Capital
California
– -$35K -5,564 Closed
1
2